Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck E. Nicolini(Université Claude Bernard Lyon 1), Christine Lombard(Inserm), Fiorenza Barraco(Hôpital Lyon Sud), Mohamad Sobh(Ottawa Hospital), Xavier Thomas(Hospices Civils de Lyon), Colette Chapuis‐Cellier(Inserm), Hélène Labussière(Hôpital Lyon Sud), Mohamed Elhamri(Hôpital Edouard Herriot)
Cited by 9
Related Papers
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
|The Lancet Haematology|2016|431
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
|Bone Marrow Transplantation|2015|387
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309